Infectious Complications of Kidney Transplantation
View More View Less
  • 1 Division of Nephrology and Transplantation, Maine Medical Center, and Tufts University School of Medicine, Portland, Maine
  • 2 Division of Renal Diseases and Hypertension, Transplant Center, University of Colorado Denver, Aurora, Colorado
  • 1.

    Heo NY, Mannalithara A, Kim D, Udompap P, Tan JC, Kim WR: Long-term patient and graft survival of kidney transplant recipients with hepatitis C virus infection in the United States. Transplantation 102: 454460, 2018 PubMed

    • Search Google Scholar
    • Export Citation
  • 2.

    Dörr G, Del Bello A, Abravanel F, Marion O, Cointault O, Ribes D, : Malignancies in hepatitis C virus-positive and -negative kidney transplant recipients: A case-controlled study. Transpl Infect Dis 19: 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 3.

    Gupta G, Kang L, Yu JW, Limkemann AJ, Garcia V, Bandyopadhyay D, : Long-term outcomes and transmission rates in hepatitis C virus-positive donor to hepatitis C virus-negative kidney transplant recipients: Analysis of United States national data. Clin Transplant 31: 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 4.

    McCauley M, Mussell A, Goldberg D, Sawinski D, Molina RN, Tomlin R, : Race, risk, and willingness of end-stage renal disease patients without hepatitis C virus to accept an HCV-infected kidney transplant. Transplantation 102: e163e170, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 5.

    Chascsa DM, Mousa OY, Pungpapong S, Zhang N, Chervenak A, Nidamanuri S, : Clinical outcomes of hepatitis C treatment before and after kidney transplantation and its impact on time to transplant: A multicenter study. Am J Transplant 18: 25592565, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 6.

    Colombo M, Aghemo A, Liu H, Zhang J, Dvory-Sobol H, Hyland R, : Treatment with ledipasvir-sofosbuvir for 12 or 24 weeks in kidney transplant recipients with chronic hepatitis C virus genotype 1 or 4 infection: A randomized trial. Ann Intern Med 166: 109117, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 7.

    Fernández I, Muñoz-Gómez R, Pascasio JM, Baliellas C, Polanco N, Esforzado N, : Efficacy and tolerability of interferon-free antiviral therapy in kidney transplant recipients with chronic hepatitis C. J Hepatol 66: 718723, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 8.

    Huang H, Tang H, Deng H, Shen J, Zhou Q, Xie W, : Treatment of chronic hepatitis C viral infection with sofosbuvir and daclatasvir in kidney transplant recipients. Transpl Infect Dis 21: e13018, 2019 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 9.

    Lin MV, Sise ME, Pavlakis M, Amundsen BM, Chute D, Rutherford AE, : Efficacy and safety of direct acting antivirals in kidney transplant recipients with chronic hepatitis C virus infection. PLoS One 11: e0158431, 2016 PubMed

    • Search Google Scholar
    • Export Citation
  • 10.

    Lubetzky M, Chun S, Joelson A, Coco M, Kamal L, Ajaimy M, : Safety and efficacy of treatment of hepatitis C in kidney transplant recipients with directly acting antiviral agents. Transplantation 101: 17041710, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 11.

    Sawinski D, Shelton BA, Mehta S, Reed RD, MacLennan PA, Gustafson S, : Impact of protease inhibitor-based anti-retroviral therapy on outcomes for HIV+ kidney transplant recipients. Am J Transplant 17: 31143122, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 12.

    Boyle SM, Malat G, Harhay MN, Lee DH, Pang L, Talluri S, : Association of tenofovir disoproxil fumarate with primary allograft survival in HIV-positive kidney transplant recipients. Transpl Infect Dis 19: 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 13.

    Ebcioglu Z, Liu C, Shapiro R, Rana M, Salem F, Florman S, : Belatacept conversion in an HIV-positive kidney transplant recipient with prolonged delayed graft function. Am J Transplant 16: 32783281, 2016 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 14.

    Kuten SA, Patel SJ, Baru A, Gaber AO, Crutchley RD, Ramanathan V, : Belatacept conversion in an HIV-positive kidney transplant recipient following anti-thymocyte globulin induction. Transpl Infect Dis 19: 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 15.

    Muller E, Barday Z: HIV-positive kidney donor selection for HIV-positive transplant recipients. J Am Soc Nephrol 29: 10901095, 2018 PubMed

  • 16.

    Ailioaie O, Arzouk N, Valantin MA, Tourret J, Calin RO, Turinici M, : Infectious complications in HIV-infected kidney transplant recipients. Int J STD AIDS 29: 341349, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 17.

    Sawinski D, Lee DH, Doyle AM, Blumberg EA: Successful posttransplant treatment of hepatitis C with ledipasvir-sofosbuvir in HIV+ kidney transplant recipients. Transplantation 101: 974979, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 18.

    Locke JE, Shelton BA, Reed RD, MacLennan PA, Mehta S, Sawinski D, : Identification of optimal donor-recipient combinations among human immunodeficiency virus (HIV)-positive kidney transplant recipients. Am J Transplant 16: 23772383, 2016 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 19.

    Natori Y, Humar A, Husain S, Rotstein C, Renner E, Singer L, : Recurrence of CMV infection and the effect of prolonged antivirals in organ transplant recipients. Transplantation 101: 14491454, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 20.

    Gatault P, Al-Hajj S, Noble J, Chevallier E, Piollet M, Forconi C, : CMV-infected kidney grafts drive the expansion of blood-borne CMV-specific T cells restricted by shared class I HLA molecules via presentation on donor cells. Am J Transplant 18: 19041913, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 21.

    Higdon LE, Trofe-Clark J, Liu S, Margulies KB, Sahoo MK, Blumberg E, : Cytomegalovirus-responsive CD8+ T cells expand after solid organ transplantation in the absence of CMV disease. Am J Transplant 17: 20452054, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 22.

    Meesing A, Abraham RS, Razonable RR: Clinical correlation of cytomegalovirus infection with CMV-specific CD8+ T-cell immune competence score and lymphocyte subsets in solid organ transplant recipients. Transplantation 103: 832838, 2019 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 23.

    Jarque M, Melilli E, Crespo E, Manonelles A, Montero N, Torras J, : CMV-specific cell-mediated immunity at 3-month prophylaxis withdrawal discriminates D+/R+ kidney transplants at risk of late-onset CMV infection regardless the type of induction therapy. Transplantation 102: e472e480, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 24.

    Vincenti F, Budde K, Merville P, Shihab F, Ram Peddi V, Shah M, : A randomized, phase 2 study of ASP0113, a DNA-based vaccine, for the prevention of CMV in CMV-seronegative kidney transplant recipients receiving a kidney from a CMV-seropositive donor. Am J Transplant 18: 29452954, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 25.

    Mallat SG, Tanios BY, Itani HS, Lotfi T, McMullan C, Gabardi S, : CMV and BKPyV infections in renal transplant recipients receiving an mTOR inhibitor-based regimen versus a CNI-based regimen: A systematic review and meta-analysis of randomized, controlled trials. Clin J Am Soc Nephrol 12: 13211336, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 26.

    Leboeuf C, Wilk S, Achermann R, Binet I, Golshayan D, Hadaya K, ; Swiss Transplant Cohort Study: BK polyomavirus-specific 9mer CD8 T cell responses correlate with clearance of BK viremia in kidney transplant recipients: First report from the Swiss Transplant Cohort Study. Am J Transplant 17: 25912600, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 27.

    Gupta G, Kuppachi S, Kalil RS, Buck CB, Lynch CF, Engels EA: Treatment for presumed BK polyomavirus nephropathy and risk of urinary tract cancers among kidney transplant recipients in the United States. Am J Transplant 18: 245252, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 28.

    Thangaraju S, Gill J, Wright A, Dong J, Rose C, Gill J: Risk factors for BK polyoma virus treatment and association of treatment with kidney transplant failure: insights from a paired kidney analysis. Transplantation 100: 854861, 2016 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 29.

    Abend JR, Changala M, Sathe A, Casey F, Kistler A, Chandran S, : Correlation of BK virus neutralizing serostatus with the incidence of BK viremia in kidney transplant recipients. Transplantation 101: 14951505, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 30.

    Wunderink HF, Haasnoot GW, de Brouwer CS, van Zwet EW, Kroes ACM, de Fijter JW, : Reduced risk of BK Polyomavirus infection in HLA-B51-positive kidney transplant recipients. Transplantation 103: 604612, 2019 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 31.

    Plafkin C, Singh T, Astor BC, Parajuli S, Bhutani G, Safdar N, : Kidney transplant recipients with polycystic kidney disease have a lower risk of post-transplant BK infection than those with end-stage renal disease due to other causes. Transpl Infect Dis 20: e12974, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 32.

    Waller KMJ, Wyburn KR, Shackel NA, O’Leary MJ, Kelly PJ, Webster AC: Hepatitis transmission risk in kidney transplantation (the HINT study): A cross-sectional survey of transplant clinicians in Australia and New Zealand. Transplantation 102: 146153, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 33.

    Masutani K, Omoto K, Okumi M, Okabe Y, Shimizu T, Tsuruya K, ; Japan Academic Consortium of Kidney Transplantation (JACK) Investigators.: Incidence of hepatitis B viral reactivation after kidney transplantation with low-dose rituximab administration. Transplantation 102: 140145, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 34.

    Mulley WR, Le ST, Ives KE: Primary seroresponses to double-dose compared with standard-dose hepatitis B vaccination in patients with chronic kidney disease: A systematic review and meta-analysis. Nephrol Dial Transplant 32: 136143, 2017 PubMed

    • Search Google Scholar
    • Export Citation
  • 35.

    Querido S, Weigert A, Adragão T, Rodrigues L, Jorge C, Bruges M, : Risk of hepatitis B reactivation in hepatitis B surface antigen seronegative and core antibody seropositive kidney transplant recipients. Transpl Infect Dis 21: e13009, 2019 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 36.

    Jeon JW, Kim SM, Cho H, Baek CH, Kim H, Shin S, : Presence of hepatitis B surface antibody in addition to hepatitis B Core antibody confers protection against hepatitis B virus infection in hepatitis B surface antigen-negative patients undergoing kidney transplantation. Transplantation 102: 17171723, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 37.

    Pourbaix A, Ouali N, Soussan P, Roque Afonso AM, Péraldi MN, Rondeau E, : Evidence of hepatitis E virus transmission by renal graft. Transpl Infect Dis 19: 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 38.

    Mallet V, Sberro-Soussan R, Roque-Afonso AM, Vallet-Pichard A, Deau B, Portal A, : Transmission of hepatitis E virus with plasma exchange in kidney transplant recipients: A retrospective cohort study. Transplantation 102: 13511357, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 191 191 19
Full Text Views 539 539 41
PDF Downloads 280 280 20